Issuer · CIK 0001689375
TRDA — Entrada Therapeutics, Inc.
Recent filings
- Jun 12, 2026·Form 4·Other—
TRDA/Entrada Therapeutics, Inc.
PARMAR KUSH · director
Mechanical filing
AI thesis skipped - Jun 12, 2026·Form 4·Other—
TRDA/Entrada Therapeutics, Inc.
KIM PETER S · director
Mechanical filing
AI thesis skipped - Jun 12, 2026·Form 4·Other—
TRDA/Entrada Therapeutics, Inc.
Chapman Gina · director
Mechanical filing
AI thesis skipped - Jun 12, 2026·Form 4·Other—
TRDA/Entrada Therapeutics, Inc.
Radhakrishnan Maha · director
Mechanical filing
AI thesis skipped - Jun 12, 2026·Form 4·Other—
TRDA/Entrada Therapeutics, Inc.
Thistle Mary · director
Mechanical filing
AI thesis skipped - Jun 12, 2026·Form 4·Other—
TRDA/Entrada Therapeutics, Inc.
Zeiher Bernhardt G · director
Mechanical filing
AI thesis skipped - May 21, 2026·Form 4·Buy$29.3K
TRDA/Entrada Therapeutics, Inc.
Zeiher Bernhardt G · director
Mechanical filing
AI thesis skipped - May 4, 2026·Form 4·Sell$398.8K
TRDA/Entrada Therapeutics, Inc.
Sethuraman Natarajan · President, Research & Develop.
32conviction - May 4, 2026·Form 4·Sell$230K
TRDA/Entrada Therapeutics, Inc.
Dowden Nathan J · President & COO
8conviction - Mar 3, 2026·Form 4·Other$89.1K
TRDA/Entrada Therapeutics, Inc.
Sethuraman Natarajan · President, Research & Develop.
Mechanical filing
AI thesis skipped - Mar 3, 2026·Form 4·Other$225.5K
TRDA/Entrada Therapeutics, Inc.
Doshi Dipal · CEO
Mechanical filing
AI thesis skipped